4.6 Article

APOL1 variants and kidney disease. There is no such thing as a free lunch

期刊

NEPHROLOGY DIALYSIS TRANSPLANTATION
卷 26, 期 3, 页码 775-778

出版社

OXFORD UNIV PRESS
DOI: 10.1093/ndt/gfq753

关键词

-

向作者/读者索取更多资源

A recent study by Genovese et al. unraveled the findings of the intensively discussed gene region around MYH9 and its association with non-diabetic chronic kidney disease in African-Americans. First, it is not the genetic variation in MYH9 but in the neighbouring APOL1 that causes the strong association with disease in African-Americans and second, the study showed strong evidence for a positive selection against vulnerability for Trypanosoma brucei rhodesiense infection but at the price of a higher susceptibility of non-diabetic chronic kidney disease. This overview reviews the findings and the possible impact of the study mentioned above as well as of related studies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Medicine, General & Internal

Apolipoprotein A-IV concentrations and clinical outcomes in a large chronic kidney disease cohort: Results from the GCKD study

Johannes P. Schwaiger, Barbara Kollerits, Inga Steinbrenner, Hansi Weissensteiner, Sebastian Schoenherr, Lukas Forer, Fruzsina Kotsis, Claudia Lamina, Markus P. Schneider, Ulla T. Schultheiss, Christoph Wanner, Anna Koettgen, Kai-Uwe Eckardt, Florian Kronenberg

Summary: This study investigated the association between apoA-IV and all-cause mortality and cardiovascular outcomes in patients with CKD. The results showed that higher levels of apoA-IV were associated with lower inflammation levels and reduced risk of all-cause mortality, cardiovascular events, and heart failure.

JOURNAL OF INTERNAL MEDICINE (2022)

Editorial Material Cardiac & Cardiovascular Systems

Measuring lipoprotein(a): do it without ifs and buts

Florian Kronenberg

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)

Review Cardiac & Cardiovascular Systems

The long journey of lipoprotein(a) from cardiovascular curiosity to therapeutic target

Marlys L. Koschinsky, Florian Kronenberg

Summary: The journal Atherosclerosis, as the official publication of the European Atherosclerosis Society (EAS), has published a comprehensive collection of review articles on lipoprotein(a). This collection covers various aspects of lipoprotein(a) research, including epidemiology, genetics, non-genetic influences, pathogenicity, therapeutic developments, and measurement challenges. Along with the invited review articles, there are also original research papers on lipoprotein(a) included in an extended Atherosclerosis Special Issue.

ATHEROSCLEROSIS (2022)

Review Cardiac & Cardiovascular Systems

Lipoprotein(a) measurement issues: Are we making a mountain out of a molehill?

Florian Kronenberg

Summary: Measuring Lp(a) poses challenges due to the complex structure of its main protein component. Despite the difficulties in measurement, improving measurement standards is crucial for enhancing patient risk assessment.

ATHEROSCLEROSIS (2022)

Article Urology & Nephrology

PCSK9 and Cardiovascular Disease in Individuals with Moderately Decreased Kidney Function

Azin Kheirkhah, Claudia Lamina, Barbara Kollerits, Johanna F. Schachtl-Riess, Ulla T. Schultheiss, Lukas Forer, Peggy Sekula, Fruzsina Kotsis, Kai-Uwe Eckardt, Florian Kronenberg

Summary: The study found a significant association between higher PCSK9 concentrations and the risk of cardiovascular disease, independent of traditional risk factors including LDL cholesterol levels. This association was stronger in nonstatin users and participants with pre-existing cardiovascular disease at baseline.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

Article Clinical Neurology

A Family and a Genome-Wide Polygenic Risk Score Are Independently Associated With Stroke in a Population-Based Study

Michelle Hammerle, Lukas Forer, Sebastian Schonherr, Annette Peters, Harald Grallert, Florian Kronenberg, Christian Gieger, Claudia Lamina

Summary: This study evaluated the shared information between family history and genetic risk for stroke and found that family risk score and polygenic risk score were independently associated with stroke risk. Combining these risk measures increased the predictive power for stroke.

STROKE (2022)

Editorial Material Urology & Nephrology

Mitochondrial DNA and Kidney Function

Florian Kronenberg, Kai-Uwe Eckardt

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

Editorial Material Cardiac & Cardiovascular Systems

Lipoprotein(a) and aortic valve stenosis: work in progress

Florian Kronenberg

Summary: This article schematically illustrates the observational and genetic evidence that suggests LDL-cholesterol and lipoprotein(a) may be involved in the pathogenesis of aortic valve stenosis and/or aortic valve calcification. Recent trials with statins had no effect on the outcomes of the aortic valve. The questions about planned trials with Lp(a)-lowering drugs are listed.

EUROPEAN HEART JOURNAL (2022)

Article Medical Laboratory Technology

Development of an LC-MRM-MS-Based Candidate Reference Measurement Procedure for Standardization of Serum Apolipoprotein (a) Tests

L. Renee Ruhaak, Fred P. H. T. M. Romijn, Ilijana Begcevic Brkovic, Zsusanna Kuklenyik, Julia Dittrich, Uta Ceglarek, Andrew N. Hoofnagle, Harald Althaus, Eduardo Angles-Cano, Stefan Coassin, Vincent Delatour, Liesbet Deprez, Ioannis Dikaios, Gerhard M. Kostner, Florian Kronenberg, Alicia Lyle, Urban Prinzing, Hubert W. Vesper, Christa M. Cobbaert, Int Federation Clinical Chem Lab Med Working Grp Apolipoproteins Mass Spect

Summary: In order to ensure the accuracy and reliability of medical results from in vitro diagnostic and in-house tests, a higher order reference measurement system traceable to endorsed reference measurement procedures and reference materials is needed. A candidate reference measurement procedure for serum apolipoprotein(a) [apo(a)] based on mass spectrometry was developed and provisionally validated. The method demonstrated accurate quantitation of serum apo(a) and fulfilled predefined analytical performance specifications.

CLINICAL CHEMISTRY (2023)

Article Cardiac & Cardiovascular Systems

Major cardiovascular events and subsequent risk of kidney failure with replacement therapy: a CKD Prognosis Consortium study

Patrick B. Mark, Juan J. Carrero, Kunihiro Matsushita, Yingying Sang, Shoshana H. Ballew, Morgan E. Grams, Josef Coresh, Aditya Surapaneni, Nigel J. Brunskill, John Chalmers, Lili Chan, Alex R. Chang, Rajkumar Chinnadurai, Gabriel Chodick, Massimo Cirillo, Dick de Zeeuw, Marie Evans, Amit X. Garg, Orlando M. Gutierrez, Hiddo J. L. Heerspink, Gunnar H. Heine, William G. Herrington, Junichi Ishigami, Florian Kronenberg, Jun Young Lee, Adeera Levin, Rupert W. Major, Angharad Marks, Girish N. Nadkarni, David M. J. Naimark, Christoph Nowak, Mahboob Rahman, Charumathi Sabanayagam, Mark Sarnak, Simon Sawhney, Markus P. Schneider, Varda Shalev, Jung-Im Shin, Moneeza K. Siddiqui, Nikita Stempniewicz, Keiichi Sumida, Jose M. Valdivielso, Jan van den Brand, Angela Yee-Moon Wang, David C. Wheeler, Lihua Zhang, Frank L. J. Visseren, Benedicte Stengel

Summary: This study investigated the association between cardiovascular disease (CVD) and future risk of kidney failure with replacement therapy (KFRT). It found that both prevalent and incident CVD were strongly associated with KFRT risk, with incident HF showing the strongest association.

EUROPEAN HEART JOURNAL (2023)

Article Cardiac & Cardiovascular Systems

Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society

Florian Kronenberg, Samia Mora, Erik S. G. Stroes, Brian A. Ference, Benoit J. Arsenault, Lars Berglund, Marc R. Dweck, Marlys L. Koschinsky, Gilles Lambert, Francois Mach, Catherine J. McNeal, Patrick M. Moriarty, Pradeep Natarajan, Borge G. Nordestgaard, Klaus G. Parhofer, Salim S. Virani, Arnold von Eckardstein, Gerald F. Watts, Jane K. Stock, Kausik K. Ray, Lale S. Tokgozoglu, Alberico L. Catapano

Summary: In 2022, the European Atherosclerosis Society (EAS) released a new consensus statement on the relationship between lipoprotein(a) [Lp(a)] and atherosclerotic cardiovascular disease (ASCVD) and aortic stenosis. This statement highlights the importance of understanding Lp(a) concentration and its impact on lifetime risk for ASCVD. It also provides practical advice on using Lp(a) concentration to manage risk factors, despite the lack of currently available targeted therapies to lower Lp(a).

ATHEROSCLEROSIS (2023)

Article Biochemistry & Molecular Biology

Haplogrep 3-an interactive haplogroup classification and analysis platform

Sebastian Schoenherr, Hansi Weissensteiner, Florian Kronenberg, Lukas Forer

Summary: This paper presents a major upgrade to the Haplogrep software, including added features such as haplogroup summary statistics and variant annotations from various genome databases, improved algorithms for large-scale data, and a new web framework. These improvements allow researchers to classify and investigate thousands of samples more conveniently.

NUCLEIC ACIDS RESEARCH (2023)

Article Medicine, General & Internal

Cardiovascular Risk Factor Control in 70-to 95-Year-Old Individuals: Cross-Sectional Results from the Population-Based AugUR Study

Ferdinand J. Donhauser, Martina E. Zimmermann, Anna B. Steinkirchner, Simon Wiegrebe, Alexander Dietl, Caroline Brandl, Ralph Burkhardt, Andre Gessner, Frank Schweda, Tobias Bergler, Elke Schaeffner, Carsten A. Boeger, Florian Kronenberg, Andreas Luchner, Klaus J. Stark, Iris M. Heid

Summary: Cardiovascular risk factors are common in old-aged individuals, but there is limited population-based data on their control in this population. The AugUR cohort study analyzed the cardiovascular risk factor control in the 70+-year-old population of/near Regensburg. The study found that a significant proportion of participants had high LDL-cholesterol, HbA1c, or blood pressure levels beyond recommended levels, and these factors were associated with impaired kidney function.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Pharmacology & Pharmacy

Daring to dream: Targeting lipoprotein(a) as a causal and risk-enhancing factor

Marlys L. Koschinsky, Erik S. G. Stroes, Florian Kronenberg

Summary: This review focuses on the causal association between Lipoprotein(a) (Lp(a)) and cardiovascular outcomes, the mechanisms by which elevated Lp(a) contributes to cardiovascular diseases, the metabolic insights on the production and clearance of Lp(a), and the current and future therapeutic approaches to lower Lp(a) concentrations.

PHARMACOLOGICAL RESEARCH (2023)

Article Biochemistry & Molecular Biology

Systemic Evidence for Mitochondrial Dysfunction in Age-Related Macular Degeneration as Revealed by mtDNA Copy Number Measurements in Peripheral Blood

Adriana Koller, Claudia Lamina, Caroline Brandl, Martina E. Zimmermann, Klaus J. Stark, Hansi Weissensteiner, Reinhard Wuerzner, Iris M. Heid, Florian Kronenberg, Jay Stewart

Summary: This study suggests that mtDNA copy number in blood may serve as a more accessible biomarker for age-related macular degeneration (AMD) than mtDNA copy number in the retina, providing new insights into the relationship between mtDNA-CN and AMD.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

暂无数据